Adjunctive colposcopy technologies for assessing suspected cervical abnormalities: the DYSIS colposcope with DYSISmap and the ZedScan I (DG32)Product type:GuidanceProgramme:Diagnostics guidancePublished: 25 April 2018
AI-derived computer-aided detection (CAD) software for detecting and measuring lung nodules in CT scan images (DG55)Product type:GuidanceProgramme:Diagnostics guidancePublished: 5 July 2023
Artificial intelligence (AI)-derived software to help clinical decision making in stroke (DG57)Product type:GuidanceProgramme:Diagnostics guidanceLast updated: 2 May 2024Published: 23 January 2024
Artificial intelligence software to help detect and characterise colorectal polypsStatus:In developmentProgramme:Diagnostics guidanceExpected publication date: 22 January 2026
Atrial fibrillation and heart valve disease: self-monitoring coagulation status using point-of-care coagulometers (the CoaguChek XS system) (DG14)Product type:GuidanceProgramme:Diagnostics guidanceLast updated: 19 December 2017Published: 24 September 2014
Automated ankle brachial pressure index measurement devices to detect peripheral arterial disease in people with leg ulcers (DG52)Product type:GuidanceProgramme:Diagnostics guidancePublished: 24 May 2023
Biomarker tests to help diagnose preterm labour in women with intact membranes (DG33)Product type:GuidanceProgramme:Diagnostics guidancePublished: 4 July 2018
Depth of anaesthesia monitors – Bispectral Index (BIS), E-Entropy and Narcotrend-Compact M (DG6)Product type:GuidanceProgramme:Diagnostics guidancePublished: 21 November 2012
Detecting, managing and monitoring haemostasis: viscoelastometric point‑of‑care testing (ROTEM, TEG and Sonoclot systems) (DG13)Product type:GuidanceProgramme:Diagnostics guidancePublished: 20 August 2014
Devices for remote monitoring of Parkinson’s disease (DG51)Product type:GuidanceProgramme:Diagnostics guidanceLast updated: 25 January 2024Published: 25 January 2023
EGFR‑TK mutation testing in adults with locally advanced or metastatic non-small-cell lung cancer (DG9)Product type:GuidanceProgramme:Diagnostics guidancePublished: 14 August 2013
FibroScan for assessing liver fibrosis and cirrhosis outside secondary and specialist care (DG48)Product type:GuidanceProgramme:Diagnostics guidancePublished: 7 June 2023
Fluorouracil chemotherapy: The My5‑FU assay for guiding dose adjustment (DG16)Product type:GuidanceProgramme:Diagnostics guidancePublished: 10 December 2014
Heart failure algorithms for remote monitoring in people with cardiac implantable electronic devices (DG61)Product type:GuidanceProgramme:Diagnostics guidancePublished: 24 October 2024
High-sensitivity troponin tests for the early rule out of NSTEMI (DG40)Product type:GuidanceProgramme:Diagnostics guidancePublished: 26 August 2020
High-throughput non-invasive prenatal testing for fetal RHD genotype (DG25)Product type:GuidanceProgramme:Diagnostics guidancePublished: 9 November 2016
ImmunoCAP ISAC 112 for multiplex allergen testing (DG24)Product type:GuidanceProgramme:Diagnostics guidancePublished: 18 May 2016
Implantable cardiac monitors to detect atrial fibrillation after cryptogenic stroke (DG41)Product type:GuidanceProgramme:Diagnostics guidancePublished: 2 September 2020
Intraoperative tests (RD‑100i OSNA system and Metasin test) for detecting sentinel lymph node metastases in breast cancer (DG8)Product type:GuidanceProgramme:Diagnostics guidancePublished: 7 August 2013
Lead-I ECG devices for detecting symptomatic atrial fibrillation using single time point testing in primary care (DG35)Product type:GuidanceProgramme:Diagnostics guidancePublished: 8 May 2019
Molecular testing strategies for Lynch syndrome in people with colorectal cancer (DG27)Product type:GuidanceProgramme:Diagnostics guidancePublished: 22 February 2017
MRI-based technologies for assessing non-alcoholic fatty liver disease (DG50)Product type:GuidanceProgramme:Diagnostics guidancePublished: 12 January 2023
MRI fusion biopsy systems for diagnosing prostate cancer (DG53)Product type:GuidanceProgramme:Diagnostics guidancePublished: 24 May 2023
MT656 Paige Prostate AI system for the detection of prostate cancerStatus:Topic selectionProgramme:Diagnostics guidanceExpected publication date: TBC
Multiple frequency bioimpedance devices to guide fluid management in people with chronic kidney disease having dialysis (DG29)Product type:GuidanceProgramme:Diagnostics guidancePublished: 21 June 2017
New generation cardiac CT scanners (Aquilion ONE, Brilliance iCT, Discovery CT750 HD and Somatom Definition Flash) for cardiac imaging in people with suspected or known coronary artery disease in whom imaging is difficult with earlier generation CT scanners (DG3)Product type:GuidanceProgramme:Diagnostics guidanceLast updated: 6 July 2017Published: 25 January 2012
PLGF-based testing to help diagnose suspected preterm pre-eclampsia (DG49)Product type:GuidanceProgramme:Diagnostics guidancePublished: 27 July 2022
Point-of-care creatinine devices to assess kidney function before CT imaging with intravenous contrast (DG37)Product type:GuidanceProgramme:Diagnostics guidancePublished: 13 November 2019
Procalcitonin testing for diagnosing and monitoring sepsis (ADVIA Centaur BRAHMS PCT assay, BRAHMS PCT Sensitive Kryptor assay, Elecsys BRAHMS PCT assay, LIAISON BRAHMS PCT assay and VIDAS BRAHMS PCT assay) (DG18)Product type:GuidanceProgramme:Diagnostics guidancePublished: 7 October 2015
QAngio XA 3D QFR and CAAS vFFR imaging software for assessing coronary stenosis during invasive coronary angiography (DG43)Product type:GuidanceProgramme:Diagnostics guidancePublished: 17 March 2021
Rapid tests for group A streptococcal infections in people with a sore throat (DG38)Product type:GuidanceProgramme:Diagnostics guidancePublished: 13 November 2019
SepsiTest assay for rapidly identifying bloodstream bacteria and fungi (DG20)Product type:GuidanceProgramme:Diagnostics guidanceLast updated: 19 February 2020Published: 10 February 2016
Testing strategies for Lynch syndrome in people with endometrial cancer (DG42)Product type:GuidanceProgramme:Diagnostics guidancePublished: 28 October 2020
Tests in secondary care to identify people at high risk of ovarian cancer (DG31)Product type:GuidanceProgramme:Diagnostics guidancePublished: 15 November 2017
Tests to help assess risk of acute kidney injury for people being considered for critical care admission (ARCHITECT and Alinity i Urine NGAL assays, BioPorto NGAL test and NephroCheck test) (DG39)Product type:GuidanceProgramme:Diagnostics guidancePublished: 17 June 2020
The EOS 2D/3D imaging system (DG1)Product type:GuidanceProgramme:Diagnostics guidancePublished: 26 October 2011
Therapeutic monitoring of TNF-alpha inhibitors in Crohn’s disease (LISA-TRACKER ELISA kits, IDKmonitor ELISA kits, and Promonitor ELISA kits) (DG22)Product type:GuidanceProgramme:Diagnostics guidancePublished: 17 February 2016
Therapeutic monitoring of TNF-alpha inhibitors in rheumatoid arthritis (DG36)Product type:GuidanceProgramme:Diagnostics guidancePublished: 10 July 2019
Virtual chromoendoscopy to assess colorectal polyps during colonoscopy (DG28)Product type:GuidanceProgramme:Diagnostics guidancePublished: 10 May 2017
VivaScope 1500 and 3000 imaging systems for detecting skin cancer lesions (DG19)Product type:GuidanceProgramme:Diagnostics guidancePublished: 11 November 2015